Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis

NCT00211601 is registered in ClinicalTrials.gov with Merck Sharp & Dohme LLC as lead sponsor.

NCT NCT00211601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00211601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis
Lead sponsor
Merck Sharp & Dohme LLC
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2004
Completion date
December 31, 2005
Enrollment
1,500
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy induced nausea and vomiting